PPARA and metabolic dysfunction-associated steatotic liver disease: Taken together, the effect of fenofibrate to ameliorate NAFLD-like symptoms was limited in AAV-Mir20b administrated HFD-fed mice because of the targeting PPARα by Mir20b.